CareRx Corporation

CRRX

CA14173C1059

Drug Retailers

Market Closed - Toronto S.E. Other stock markets 03:59:03 2024-05-14 pm EDT			5-day change	1st Jan Change
2.13 ^CAD	+4.41%		+0.47%	+32.30%

May. 13	CareRx Brief: Company Undertaking a search for a new CFO; Davide Pernarella, currently Vice President, Business Planning and Analysis at CareRx, will assume the role of Interim CFO	MT
May. 13	CareRx Brief: Says Andrew Mok will step down as Chief Financial Officer effective June 7, 2024, to pursue another employment opportunity	MT

Darren Youngleson to Retire as A Director of CareRx Corporation

August 13, 2020 at 05:54 pm EDT

Effective August 14, 2020, Darren Youngleson will retire as a director of CareRx Corporation. Mr. Youngleson currently serves as a director nominee under a nomination right that was granted to Dr. Jack Shevel, one of the Company's directors and its Chairman Emeritus.

Latest news about CareRx Corporation

CareRx Brief: Company Undertaking a search for a new CFO; Davide Pernarella, currently Vice President, Business Planning and Analysis at CareRx, will assume the role of Interim CFO	May. 13	MT
CareRx Brief: Says Andrew Mok will step down as Chief Financial Officer effective June 7, 2024, to pursue another employment opportunity	May. 13	MT
Transcript : CareRx Corporation, Q1 2024 Earnings Call, May 10, 2024	May. 10
CareRx Q1 Net Loss Narrows, Revenue Dips	May. 10	MT
CareRx Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 10	CI
CareRx Brief: Q1 Revenue $89.7 million; Net loss for the quarter was $0.5 million	May. 10	MT
North American Morning Briefing : Stocks Set to -2-	May. 10	DJ
CareRx Down 3% as Notes Ontario Government's Pause of Planned Fee Changes	Apr. 01	MT
CareRx Brief: Notes Ontario Government's Pause of Planned Fee Changes	Apr. 01	MT
CareRx Brief: In connection with Prior announced normal course issuer bid to Buy Up To 1 Million of its common shares, it has entered into an automatic share purchase plan	Mar. 27	MT
CareRx Narrows Q4 Loss, Revenue Falls	Mar. 07	MT
Transcript : CareRx Corporation, Q4 2023 Earnings Call, Mar 07, 2024	Mar. 07
CareRx Brief: Revenue for Q4 $91.1 million; Net loss for the quarter was $3.7 million	Mar. 07	MT
CareRx Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 07	CI
CareRx Corporation Reports Goodwill and Intangible Assets Impairment Charges for the Fourth Quarter Ended December 31, 2023	Mar. 07	CI
North American Morning Briefing : Powell Still in -2-	Mar. 07	DJ
North American Morning Briefing : Powell Still in the Spotlight; ECB Rate Decision Looms	Mar. 07	DJ
CareRx Corporation Announces Closing of $70 Million Debt Refinancing	Dec. 21	CI
CareRx Completes C$70-Million Debt Refinancing	Dec. 21	MT
CareRx Brief: Says Closed $70 Million Debt Refinancing	Dec. 21	MT
CareRx Announced $70 million Debt Refinancing	Dec. 11	MT
CareRx Brief: Announcing $70 million Debt Refinancing	Dec. 11	MT
CareRx Corporation Announces $70 Million Debt Refinancing	Dec. 11	CI
Transcript : CareRx Corporation, Q3 2023 Earnings Call, Nov 08, 2023	Nov. 08
Tranche Update on CareRx Corporation's Equity Buyback Plan announced on August 28, 2023.	Nov. 08	CI

Chart CareRx Corporation

Duration

Period

More charts

Company Profile

CareRx Corporation is a Canada-based provider of pharmacy services to seniors living communities. The Company serves over 94,000 residents in over 1,500 senior and other congregate care communities, including long-term care homes, retirement homes, assisted living facilities, and group homes. It supports its home care partners by providing solutions for the supply of chronic medication. It offers a range of medication solutions. Its technology automates the preparation and verification of multi-dose compliance packaging of medication, providing the safety and adherence for individuals with complex medication regimes. Its network of pharmacy fulfillment centers delivers solutions for the supply of chronic medication and other specialty clinical pharmacy services. The Company provides services in rural and urban areas throughout Ontario, Alberta, British Columbia, and parts of Saskatchewan. It works with home operator partners to promote resident health, staff education and others.

Sector

Drug Retailers

Calendar

2024-05-29 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Ratings for CareRx Corporation

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

2.13 CAD

Average target price

3.781 CAD

Spread / Average Target

+77.52%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Drug Retailers

	1st Jan change	Capi.
CARERX CORPORATION	+32.30%	89.71M
WALGREENS BOOTS ALLIANCE, INC.	-29.72%	15.63B
JD HEALTH INTERNATIONAL INC.	-22.89%	12.43B
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED	-24.53%	6.57B
YIFENG PHARMACY CHAIN CO., LTD.	+15.23%	6.46B
MATSUKIYOCOCOKARA & CO.	-12.21%	6.04B
NAHDI MEDICAL COMPANY	-1.90%	4.63B
CORPORATIVO FRAGUA, S.A.B. DE C.V.	+62.00%	4.61B
CLICKS GROUP LIMITED	-5.94%	3.94B
DASHENLIN PHARMACEUTICAL GROUP CO., LTD.	-9.36%	3.51B

Other Drug Retailers

CareRx Corporation

Equities

CRRX

CA14173C1059

Drug Retailers

Darren Youngleson to Retire as A Director of CareRx Corporation

EPS Revisions